These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3901389)

  • 1. The effect of the synthetic steroid Org OD14 on fibrinolysis and blood lipids in postmenopausal women.
    Walker ID; Davidson JF; Richards A; Yates R; McEwan HP
    Thromb Haemost; 1985 Jun; 53(3):303-5. PubMed ID: 3901389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A preliminary report on the treatment of climacteric symptoms with Org OD14].
    Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):539-41, 569-70. PubMed ID: 8313747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of conjugated estrogen and Org OD14 on serum lipoprotein and apolipoprotein in perimenopausal and postmenopausal women].
    Bai W; Yang X; Zheng S
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):293-6. PubMed ID: 11326938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14.
    Cortes-Prieto J
    Maturitas; 1987; Suppl 1():67-72. PubMed ID: 3306292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of a new steroid (Org OD 14) in the climacteric syndrome].
    Cittadini J; Ben J; Badano AR; Denari HJ; Quiroga S; Marcus AE; Schlaen I; Figueroa Casas PR
    Reproduccion; 1982; 6(2):69-79. PubMed ID: 6814971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New steroid for the climacteric syndrome.
    Kicovic PM
    Minerva Endocrinol; 1989; 14(1):63-7. PubMed ID: 2659954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind cross-over study on the effects of ORG OD14 compared to oestradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women.
    Crona N; Silfverstolpe G; Samsioe G
    Acta Endocrinol (Copenh); 1983 Mar; 102(3):451-5. PubMed ID: 6338679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gynecological, hematological and metabolic studies during therapy with an estrogen-gestagen combination preparation].
    Schneider WH; Matt K; Irsigler K; Lageder H; Schubert H
    Arzneimittelforschung; 1975 Jun; 25(6):959-62. PubMed ID: 1100056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women.
    Kicovic PM; Cortés-Prieto J; Luisi M; Milojevic S; Franchi F
    Reproduccion; 1982; 6(2):81-91. PubMed ID: 6754512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.
    Christodoulakos GE; Lambrinoudaki IV; Economou EV; Papadias C; Panoulis CP; Kouskouni EE; Vlachou SA; Creatsas GC
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):542-8. PubMed ID: 16680067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
    Lagrelius A; Lunell NO; Blombäck M
    Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage.
    Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
    Metabolism; 2009 Jul; 58(7):1030-8. PubMed ID: 19411087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoproteins in soy-treated postmenopausal women: a double-blind, placebo-controlled trial.
    Vigna GB; Pansini F; Bonaccorsi G; Albertazzi P; Donegà P; Zanotti L; De Aloysio D; Mollica G; Fellin R
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):315-22. PubMed ID: 11302006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of long-term plasmapheresis on the composition of blood. III. Changes in the concentration of total, direct and indirect bilirubin, alkaline phosphatase, serum transaminases (SGOT, SGPT). total lipids, triglycerides and cholesterol].
    Grgicević D
    Bilt Hematol Transfuz; 1983; 11(2-3):39-50. PubMed ID: 6680299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.